Diligence memo · auto-generated · as of July 2, 2026
BioCytics, Inc.
BioCytics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
BioCytics, Inc. operates in Other Health Care, based in HUNTERSVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioCytics, Inc. has raised $1.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.4M on 2023-02-08.
Most recent recorded round closed around 2023-02-08.
Valuation (modeled)modeled
Provath models BioCytics, Inc. at approximately $11M (range $1.1M–$43M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.91× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Within the normal band (91% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 3.4 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 40% of Other Health Care peers (5377 compared).
Modeled value ranks above 36% of those peers.
Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.